Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows

American Journal of Veterinary Research

Volumn 60, Issue 9, 1999, Pages 1111-1116

  Bregante, Miguel A ^a   Saez, Pilar ^a   Aramayona, Jose J ^a   Fraile, Lorenzo ^a   Garcia, Maria A ^a   Solans, Carlos ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN;

ARTICLE; COW; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; RABBIT; RAT; SHEEP;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BODY WEIGHT; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, INTRAVENOUS; LEAST-SQUARES ANALYSIS; MICE; QUINOLONES; RABBITS; RATS; REGRESSION ANALYSIS; SHEEP; ULTRAFILTRATION;

ANIMALIA; MAMMALIA; ORYCTOLAGUS CUNICULUS; OVIS ARIES;

EID: 0032861871     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Prescott JF; Yielding KM. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Can J Vet Res 1990;54:195-197.
2. Walker RD, Stein GE, Hauptman JG, et al. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am J Vet Res 1992;53:2315-2319.
3. Hannan PCT, Windsor GD, de Jong A, et al. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob Agents Chemother 1997;41:2037-2040.
4. Cabanes A, Arboix M, Garcia Anton JM, et al. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. Am J Vet Res 1992;53:2090-2093.
5. Kaartinen L, Salonen M, Ālli L, et al. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J Vet Pharmacol Ther 1995;18: 357-362.
6. Pugliese A, Naccari F, Pizzimenti FC, et al. Farmacocinetica di enrofloxacin negli ovini. Documenti Veterinari 1991;12:51-54.
7. Dorrestein GM, Verburg E. Pharmacokinetics of enrofloxacin in homing pigeons, in Proceedings. 4th Congr Eur Assoc Vet Pharmacol 1988:27-30.
8. Flammer K, Aucoin DP, Whitt DA. Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. J Vet Pharmacol Ther 1991;14:359-366.
9. Vancutsem PM, Babish JG, Schwark WS. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 1990;80:173-186.
10. Broome RL, Brooks DL, Babish JG, et al. Pharmacokinetic properties of enrofloxacin in rabbits. Am J Vet Res 1991;52: 1835-1841.
11. Bowser PR, Wooster GA, St Leger J, Babish JG. Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynchus mykiss). J Vet Pharmacol Ther 1992;15:62-71.
12. Brown SA. Fluoroquinolones in animal health J Vet Pharmacol Ther 1996;19:1-14.
13. Boothe DM. Enrofloxacin revisited. Vet Med 1994;89: 744-753.
14. Küng K, Riond M, Wanner M. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J Vet Pharmacol Ther 1993:16:462-468.
15. Küng K, Wanner M. Pharmakokinetik von Baytril (enrofloxacin). Schweiz Arch Tierheilkd 1994;136:329-334.
16. Boxenbaum H. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 1982;10:201-227.
17. Weiss M, Sziegoleit W, Forster W. Dependence of pharmacokinetic parameter on the body weight. Int J Clin Pharmacol 1977;15:572-575.
18. Bonati M, Latini R, Tognoni G. Interspecies comparision of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat and mouse. Drug Metab Rev 1984;15:1355-1383.
19. Owens SM, Hardwick WC, Blackall D. Phencyclidine pharmacokinetic scaling among species. J Pharmacol Exp Ther 1987;242: 96-101.
20. McGovren JP, Williams MG, Stewart JC. Interspecies comparision of acivicin pharmacokinetics. Drug Metab Disp 1988;16: 18-22.
21. Swabb EA, Bonner DP. Prediction of aztreonam pharmacokinetics in humans based on data from animals. J Pharmacokinet Biopharm 1983;11:215-223.
22. Sawada Y, Hanano M, Sugiyama Y, et al. Prediction of the disposition of nine weak acidic and six weak basic drugs in humans from pharmacokinetic parameters in rats. J Pharmacokinet Biopharm 1985;13:477-492.
23. Mordenti J. Forecasting cephalosporin and monolactam antibiotic halflives in humans from data collected in laboratory animals. Antimicrob Agents Chemother 1985;27:887-891.
24. Nilsson-Ehle I. Assay of ciprofloxacin and norfloxacin in serum and urine by high-performance liquid chromatography. J Chrommogr A1987;416:207-211.
25. Aramayona JJ, Garcia MA, Fraile LJ, et al. Placental transfer of enrofloxacin and ciprofloxacin in rabbits. Am J Vet Res 1994;55:1313-1318.
26. Aramayona JJ, Mora J, Fraile L, et al. Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. Am J Vet Res 1996;57:547-553.
27. Mengozzi G, Intorre L, Benin S, et al. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep. Am J Vet Res 1996;57: 1040-1043.
28. Richez P, Dellac B, Froyman R. Pharmacokinetics of enrofloxacin in pigs after single and repeated in-feed medication with Baytril I.E.R. 2.5%. J Vet Pharmacol Ther 1994;6th EAVPT Congress: 207-208.
29. Giguere S, Sweeney RW, Belanger M. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. Am J Vet Res 1996;57:1025-1030.
30. Pyörala S, Panu S, Kaartinen L. Single-dose pharmacokinetics of enrofloxacin in horses. J Vet Phamacol Ther 1994;6th EAVPT Congress:45-46.
31. Richez P, Monlouis JD, Dellac B, et al. Validation of a therapeutic regimen for enrofloxacin in cats on the basis of pharmacokinetic data. J Vet Pharmacol Ther 1997;20(suppl 1):152-153.
32. Aramayona JJ, Bonati M, Bortolotti A, et al. Plasma protein binding of theophylline during development in the rabbit. Biol Neonote 1991;60:377-384.
33. Mitsuhashi Y, Sugiyama Y, Ozawa S, et al. Prediction of ACNU plasma concentration-times profiles in humans by animal scale-up. Cancer Chemother Pharmacol 1990;27:20-26.
34. Boxenbaum HG. Comparative pharmacokinetics of benzodiazepines in dog and man. J Pharmacokinet Biopharm 1982;10: 411-436.
35. Lashev LD, Pashov DA, Marinkov TN. Interspecies differences in the pharmacokinetics of kanamycin and apramycin. Vet Res Commun 1992;16:293-300.
36. Kirkwood JK, Widdowson MA. Interspecies variation in plasma halflife of oxytetracycline between species in relation to body weight. Res Vet Sci 1990;48:180-183.
37. Boxenbaum H, Ron R. Interspecies pharmacokinetic scaling and the Dedrick plots. Am J Physiol 1983;245:768-775.
38. Tyczkowska K, Heden KM, Aucoin AP. High performance liquid Chromatographic method for simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum. J Chromatogr A 1989;493:337-346.
39. Anadón A, Martinez-Larranaga MR, Diaz MJ, et al. Pharmacokinetics and residues of enrofloxacin in chickens. Am J Vet Res 1995;56:501-506.
40. Monlouis JD, de Jong A, Limet A, et al. Plasma pharmacokinetics and urine concentrations of enrofloxacin after oral administration of enrofloxacin in dogs. J Vet Pharmacol Ther 1997;20(suppl 1):61-63.
41. Richez P, Dellac B, Froyman R, et al. Pharmacokinetics of enrofloxacin in calves and adult cattle after single and repeated subcutaneous injections. J Vet Pharmacol Ther 1994;6th EAVPT Congress:232-234.
42. Richez P, Pedersen Morner A, de Jong A, et al. Plasma pharmacokinetic of parenterally administered danofloxacin and enrofloxacin in pigs. J Vet Pharmacol Ther 1997;20(suppl 1):41-42.
43. Nielsen P, Gyrd-Hansen N. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacol Toxicol 1997;80:246-250.
44. Boxenbaum H. lnterspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab Rev 1984;15: 1071-1121.
45. Calder WA III. Size, function and life history. Cambridge, Mass: Harvard University Press, 1984;1-431.
46. McKellar QA. Clinical relevance of the pharmacologic properties of fluoroquinolones. Compend Contin Educ Pract Vet 1996;18: 14-21.